Long term disease modification using immunostimulatory oligonucleotides
US9333254B2 · kind B2 · utility
0Cited by
22References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 18, 2014 |
| Grant date | May 10, 2016 |
| Priority date | — |
| Expiry date | Jul 18, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/57
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods for treating asthma by using multiple rounds of administration of ISS over a period of time to confer long term disease modification.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.